Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.

PropertyValue
has major subject area list Amyloidosis; Antineoplastic Agents, Alkylating; Heart Diseases; Melphalan
information resource reference Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9. PMID: 12060126.
label Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.

Highlights
Search Criteria
  • AL
  • amyloidosis